Open access
Open access
Powered by Google Translator Translator

Nephrology

KDIGO Controversies Conference: Heart Failure in Chronic Kidney Disease

30 Apr, 2019 | 02:44h | UTC

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference – Kidney International (free) (via @paomorejon)

 


Guideline: Hemolytic Uremic Syndrome in a Developing Country

30 Apr, 2019 | 02:13h | UTC

Hemolytic uremic syndrome in a developing country: Consensus guidelines – Pediatric Nephrology (free)

 


Fibrillary Glomerulonephritis: An Update

30 Apr, 2019 | 02:07h | UTC

Fibrillary Glomerulonephritis: An Update – Kidney International Reports (free)

 


Study: Half of Older Patients Starting Dialysis Die Within One Year

29 Apr, 2019 | 01:06h | UTC

One-Year Mortality After Dialysis Initiation Among Older Adults – JAMA Internal Medicine (free for a limited period)

Commentaries: Older Adults Starting Dialysis Die at Higher Rates than Previously Thought – Harvard Medical School (free) AND More than half of older dialysis patients die within a year – UPI (free)

 


2019 Chinese Guideline for the Management of Hypertension in the Elderly

28 Apr, 2019 | 13:35h | UTC

2019 Chinese guideline for the management of hypertension in the elderly – Journal of Geriatric Cardiology (free)

 


Review: Acute Management of Hyperkalemia

28 Apr, 2019 | 13:33h | UTC

Acute Management of Hyperkalemia – Current Heart Failure Reports (free)

Related: Management of Hyperkalemia in the Acutely Ill Patient (free reviews)

 


Randomized Trial: Combined Immunosuppressive Treatment (CIST) in Lupus Nephritis

28 Apr, 2019 | 13:15h | UTC

Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study – Clinical Rheumatology (free)

 


Clinical Guideline for Urinary Stone Disease

26 Apr, 2019 | 02:09h | UTC

The Urological Association of Asia clinical guideline for urinary stone disease – International Journal of Urology (free)

Related: NICE Guideline – Renal and Ureteric Stones: Assessment and Management (free guidelines)

 


Review: Hepatorenal Syndrome

24 Apr, 2019 | 06:21h | UTC

Hepatorenal Syndrome – Clinical Journal of American Society of Nephrology (free)

Related: Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome (free guidelines and reviews)

 


Beta-thalassemia: Renal Complications and Mechanisms

24 Apr, 2019 | 06:14h | UTC

Beta-thalassemia: renal complications and mechanisms: a narrative review – Hematology (free)

 


Recommendations for the Care of Patients Receiving Conservative Kidney Management

22 Apr, 2019 | 22:28h | UTC

Recommendations for the Care of Patients Receiving Conservative Kidney Management – Clinical Journal of American Society of Nephrology (free for a limited period)

 


Meta-Analysis of Randomized Trials: Effects of IV Hydration on Risk of Contrast Induced Nephropathy in STEMI patients Undergoing Primary PCI

22 Apr, 2019 | 22:26h | UTC

Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials – BMC Cardiovascular Disorders (free)

 


Management of Hypertension in Chronic Kidney Disease

19 Apr, 2019 | 08:28h | UTC

Management of Hypertension in Chronic Kidney Disease – Drugs (free)

 


KDIGO Consensus Statement: Dialysis Initiation, Modality Choice, Access, and Prescription

18 Apr, 2019 | 07:58h | UTC

Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference – Kidney International (free)

 


Randomized Trial: SGLT2 inhibitor Reduces Progression of Kidney Disease in Patients with Type 2 Diabetes and Nephropathy

16 Apr, 2019 | 02:52h | UTC

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy – New England Journal of Medicine (free for a limited period)

Commentary: Canagliflozin may offer renal protection in people with type 2 diabetes and CKD – Medicine Matters (free)

“among 1000 patients treated for 2.5 years, 21.2 individuals would need to be treated to prevent the composite primary outcome.” (from Medicine Matters)

 


Review: Acute Renal Failure of Nosocomial Origin

16 Apr, 2019 | 02:07h | UTC

Acute Renal Failure of Nosocomial Origin – Deutsches Ärzteblatt international (free)

 


Guideline: Prevention of Rhabdomyolysis‐induced Acute Kidney Injury

15 Apr, 2019 | 00:46h | UTC

Prevention of rhabdomyolysis‐induced acute kidney injury – A DASAIM/DSIT clinical practice guideline (free)

 


Study: Pruritus and Patient Reported Outcomes in Non-Dialysis CKD

15 Apr, 2019 | 00:40h | UTC

Pruritus and Patient Reported Outcomes in Non-Dialysis CKD – Clinical Journal of the American Society of Nephrology (free for a limited period)

Commentaries: Itchy Skin Affects the Health and Quality of Life of Many Patients with Kidney Disease – American Society of Nephrology (ASN) (free) AND Pruritus Common, Bothersome in Non-Dialysis CKD – Renal & Urology News (free)

 


Review: Prevention of Complications From use of Conventional Immunosuppressants

15 Apr, 2019 | 00:35h | UTC

Prevention of complications from use of conventional immunosuppressants: a critical review – Journal of Nephrology (free)

 


Compendium on the Pathophysiology and Treatment of Hypertension

12 Apr, 2019 | 01:49h | UTC

Compendium on the Pathophysiology and Treatment of Hypertension – Circulation Research (free articles)

– Homepage

– Editorial: Introduction to a Compendium on the Pathophysiology and Treatment of Hypertension

– Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management

– Two-Drug Combinations as First-Step Antihypertensive Treatment

– Preeclampsia: Pathophysiology, Challenges, and Perspectives

– Treatment of Resistant and Refractory Hypertension

– Hypertension Management in Older and Frail Older Patients

– Neurovascular and Cognitive Dysfunction in Hypertension: Epidemiology, Pathobiology, and Treatment

– Metabolic Surgery for Hypertension in Patients With Obesity

– Blood Pressure Measurement and Treatment Decisions: Masked and White-Coat Hypertension

 


Meta-Analysis: Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients with Hypertension

4 Apr, 2019 | 22:45h | UTC

Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries: Catheter-Based Renal Sympathetic Denervation Effectively Lowers BP – Cardiology Advisor (free) AND Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis – TCTMD (free)

Compared with sham control, renal denervation lowered 24-h ambulatory systolic blood pressure by 3.65 mm Hg and diastolic blood pressure by 1.71 mm Hg.

 


Review: The Efficacy and Safety of Direct Oral Anticoagulants in Patients with Chronic Renal Insufficiency

30 Mar, 2019 | 18:16h | UTC

The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: A review of the literature – European Journal of Haematology (free)

 


Study: Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease

28 Mar, 2019 | 07:11h | UTC

Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study – Pharmacotherapy (free)

Commentary: Study: Research ties common heartburn medications to kidney disease and failure – University at Buffalo (free)

Related: Meta-Analysis of Observational Studies: Proton Pump Inhibitors are Associated with Increased Risk of Kidney Disease (link to abstract – $ for full-text) AND Proton Pump Inhibitors: Review of Emerging Concerns (free reviews) AND Deprescribing Proton Pump Inhibitors (free guidelines and reviews)

 


KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

27 Mar, 2019 | 06:22h | UTC

KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline – American Journal of Kidney Diseases (free)

 


Are the Risks of Drugs That Enhance Imaging Tests Overblown?

25 Mar, 2019 | 00:28h | UTC

Are the Risks Of Drugs That Enhance Imaging Tests Overblown? – NPR (free)

Related: Meta-analysis: Acute Kidney Injury After Computed Tomography (link to abstract and commentaries) AND Reviews: Post-Contrast Acute Kidney Injury (free) AND Review: Does contrast cause kidney injury? (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.